GNLY (Gene)

Organism:

Homo sapiens

Synonyms:D2S69E, ENTREZ:10578, GNLY, HGNC:4414, LAG-2, LAG2, MIM:188855, NKG5, NM_001302758, NM_006433, NM_012483, NP_001289687, NP_006424, NP_036615, TLA519, XM_005264084, XM_005264085, XM_005264087, XP_005264141, XP_005264142, XP_005264144, granulysin

Omim:OMIM:188855

Id:aa92e98c-6b71-57a5-96fd-7b0c36a00adf

Hgnc:HGNC:4414

Entrez:10578

Ensembl:ENSG00000115523

Description:granulysin

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View GNLY's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with GNLY.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using GNLY.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for GNLY.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GNLY.

Results found

Linked to

	Label	Description
	GSE191005 ENL knockout MOLM-13 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE188570 GSE188571 decitabine 5 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE265849 MrgD overexpression muscle organ 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE262808 histone H3 inhibition 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE182150 KIT LSD1 MYC inhibition 6 v 7 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE57871 GLI1 PSMD13 knockdown HCT 116 Vorinostat 11 v 12 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE57871 vorinostat HCT 116 11 v 12 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE60217 adenosine 1 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE119345 bexarotene T cell 2 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE114492 GSE153671 KMT2D inhibition 6 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS

GSE191005 ENL knockout MOLM-13 1 v 0 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE188570 GSE188571 decitabine 5 v 2 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE265849 MrgD overexpression muscle organ 1 v 0 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE262808 histone H3 inhibition 0 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE182150 KIT LSD1 MYC inhibition 6 v 7 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE57871 GLI1 PSMD13 knockdown HCT 116 Vorinostat 11 v 12 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE57871 vorinostat HCT 116 11 v 12 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE60217 adenosine 1 v 2 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE119345 bexarotene T cell 2 v 3 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE114492 GSE153671 KMT2D inhibition 6 v 3 human dn

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.